- Home
- ATCH vs XCUR Comparison
ATCH vs XCUR Comparison
Compare ATCH & XCUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ATCH | XCUR |
|---|---|---|
| Founded | 2022 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.9M | 29.2M |
| IPO Year | 2024 | 2017 |
Fundamental Metrics
Financial Performance| Metric | ATCH | XCUR |
|---|---|---|
| Price | $0.20 | $4.31 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 18.2K |
| Earning Date | 05-15-2026 | 03-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 83.37 |
| EPS | ★ 0.06 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $3.36 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.14 | $3.10 |
| 52 Week High | $1.92 | $13.37 |
Technical Indicators
Market Signals| Indicator | ATCH | XCUR |
|---|---|---|
| Relative Strength Index (RSI) | 45.08 | 46.28 |
| Support Level | $0.18 | $3.40 |
| Resistance Level | $0.21 | $4.34 |
| Average True Range (ATR) | 0.01 | 0.36 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 70.38 | 17.66 |
Price Performance
Historical ComparisonAbout ATCH AtlasClear Holdings Inc.
AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.
About XCUR Exicure Inc.
Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology.